I am pleased to share that 11/12 (first-authored) abstracts have been accepted to #ACG2025. Grateful to my team, patients, and mentors. #ACG2025 @AmCollegeGastro

Another one. End stage liver disease with profound decompensation. Large ascites and severe coagulopathy. Acute cholecystitis treated with ERCP transcystic stent to very good effect. #gitwitter #liver #surgery @Stentingwoman ⁦@EUSandEndoscopy⁩

😛

New Original Research @PANCREASonline: First study to show that starting enteral nutrition within 48h ⏰ in predicted severe acute #pancreatitis significantly reduces 📉 ICU stay 🛌, pancreatic fluid collections, GI complications 🩸 & hospital costs 💰

#gitwitter #ercp

I did it! 🎉🎊🎉 Proud to share that I’ve officially passed the American Board of Internal Medicine (ABIM) exam. Becoming board-certified marks the culmination of years of study, resilience, and the unglamorous grind that medicine so often demands. #ABIM #IM #Grit

In this 🇵🇹 RCT with long term follow-up, exocrine pancreatic insufficiency (EPI) was common (48% EPI, 28% persistent EPI) after acute pancreatitis, has identifiable risk factors, and resolves faster with PERT 💡🆕 #UEGWeek 📸: Marta Gravito-Soares

Algorithm for medical management of obesity and its complications 🆕 📸: https://t.co/dzrmQp3Nz5

ChatIBD has processed >6M tokens and >800 messages in the first 24 hours. The platform is running stable with a few minor timeouts. If you do encounter an error, trying again usually works. Thank you to everyone testing and helping us refine this tool for the IBD community.

Two months ago, I shared that I had 11 first-authored abstracts accepted for presentation at the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix, Arizona. I’m humbled to share that one of these abstracts has been awarded the Presidential Poster Award

Indications for GLP1s: - Obesity - Diabetes - CKD and heart failure in diabetes - Bile acid diarrhoea - High output stoma 🆕 📸: https://t.co/micBkFl0G5

CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis | New England Journal of Medicine

After a decade, it was great to be virtually back to Cambridge 🇺🇸 for the @Harvard course “Management of pancreatic disorders for the practicing clinician” 🎓 Thank you @DeMadaria and @YhernandezMD for having me and to all the enthusiastic participants!

First talk of the day by the legend @DavidCWhitcomb Chronic Pancreatitis and Its Complications: Approach to the Management of Chronic Pancreatitis Management of Pancreatic Disorders for the Practicing Clinician's @harvardmed postgraduate course 2025 #HarvardPancreas2025

Exciting data on oral semaglutide, a GLP1RA dubbed the oral version of Ozempic, coming soon! 🆕⭐️

Patient selection for ERCP is an important step to prevent post-ERCP acute pancreatitis @tberzin #HarvardPancreas2025 👇👇👇👇👇

📷 Thrilled to launch our Third Space Endoscopy program at the University of Utah I had the privilege of performing the first two ESD procedures ever in the state of Utah: 📷* A 3.5 by 3 cm lesion in the ascending colon across a Haustral fold 📷* An 8 x 6 cm (80%

Thank you @iGIEjournal for highlighting my novel technique in treating a commonly faced issue during ERCP! @MetabolicEndo @BrighamGI @Alharbi_A_W @KFSHRC

Paracetamol (acetaminophen) remains the safest analgesic to take in liver failure and in pregnancy.

We are now in GI Fellowship Interview Season. I was a GI Fellowship PD x 7 years at U of Utah, so I have read through 1000s of applications and interviewed 100sof applicants. Here are my top things to remember when interviewing for GI. #gitwitter #medtwitter

I recently learned that the novelist, Cormac McCarthy, spent several years at the Santa Fe Institute helping scientists write papers. His advice was condensed into a brief Nature column. The first three points, and some of the final points, are really good. (h/t @eryney_ok)